From Donor to Recipient: Current Questions Relating to Humoral Alloimmunization

Alloimmunization is an undesirable iatrogenic effect of transfusion and transplantation. In fact, recipients can be considered as responders or not responders, in a continuum from tolerance, including organ transplantation and transfusion, to polyimmunized and refractory patients. New models and lar...

Full description

Bibliographic Details
Main Authors: Antoine Prigent, Nicolas Maillard, Léna Absi, Chaker Aloui, Fabrice Cognasse, Sandrine Laradi, Christophe Mariat, Olivier Garraud
Format: Article
Language:English
Published: MDPI AG 2014-02-01
Series:Antibodies
Subjects:
HLA
Online Access:http://www.mdpi.com/2073-4468/3/1/130
Description
Summary:Alloimmunization is an undesirable iatrogenic effect of transfusion and transplantation. In fact, recipients can be considered as responders or not responders, in a continuum from tolerance, including organ transplantation and transfusion, to polyimmunized and refractory patients. New models and large studies have enabled a better understanding of the mechanisms that induce specific alloantibody (alloAb) generation. Here, we focus on risk factors of alloimmunization. We review the alloantibody characteristics, summarize the different leukocytes involved in their induction, and suggest some hypotheses.
ISSN:2073-4468